Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma

Figure 3

Construction of the prognostic model. (a) Coefficient profiles in the LASSO Cox regression model. (b) Validation for turning parameter selection in the LASSO Cox regression model. (c) KM curve of the three genes composed of the signature. (d) The distribution and median value of the risk scores in TCGA. (e) The distributions of OS status of HCC patients in TCGA. (f) Heatmap of the 3 genes among different risk groups. (g) Expression of DEGs among different risk groups. (h) PCA showed a good distinction among risk groups. (i) Comparison of risk score between the two clusters. (j) Sankey plot showed the correlation among clusters, risk groups, and survival status.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)